Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study
ConclusionOral VRCZ administration may benefit adult patients with AML/MDS undergoing chemotherapy.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Databases & Libraries | Fungal Infections | Japan Health | Leukemia | Myelodysplastic Syndrome | Study